Burden of severe infections due to carbapenem-resistant pathogens in intensive care unit

Table 3 Worldwide prevalence of Meropenem-resistant Enterobacteriales, n %

Continent	Country	Pathogen	Prevalence	Site of infection	Ref.
Africa	Egypt	Enterobacter cloacae; Escherichia coli; Klebsiella pneumoniae	43.5; 27.1; 53.7	Mix	[96]
	Morocco	Enterobacteriales	2.6	Mix	[97]
	South Africa	Enterobacter spp. Other; Klebsiella spp.	18; 6; 18	Mix	[98]
	Tunisia	Enterobacter aerogenes; Enterobacter cloacae; Escherichia coli; K. Pneumonia; Providencia Stuartii	0.9; 9.8; 2.9; 85.2; 0.9	Mix	[58]
America	Argentina	Enterobacteriales	2.8	BSI	[99]
	Canada	Enterobacter cloacae; Escherichia coli; K. pmeumoniae; S marcescens	0.8; 0.1; 0.2;0.5	Mix	[41]
	United States	Citrobacter spp.; Enterobacter aerogenes; Enterobacter cloacae; Escherichia coli; Klebsiella oxytoca; Klebsiella pneumonia	4; 6; 42; 14; 4; 30	Mix	[87,88,100,101]
Asia	China	Escherichia coli; Klebsiella Pneumoniae	11.9; 57-76.7	Mix	[56,57,102]
	India	Klebsiella spp.	54	Mix	[103]
	Iran	Klebsiella Pneumoniae	25.3	Mix	[104]
	Korea	Enterobacteriales	31.1	BSI	[49]
	Pakistan	Klebsiella Pneumoniae	72	Mix	[97]
	Turkey	Klebsiella Pneumoniae	44.7-67.47	Mix	[105]
Europe	France	Enterobacteriales	72.8	Mix	[106]
	Germany	Escherichia coli; Klebsiella Pneumoniae	3; 13	Mix	[75]
	Greece	Klebsiella pneumoniae	74	NS	[107]
	Russia	Escherichia coli; Klebsiella spp.; Proteus spp.	3; 16; 29	NS	[108]
	Serbia	Enterobacter spp.	36.4/35.9	HAC/VAP	[81]
		Klebsiella pneumoniae	50/56.8
		Proteus mirabilis	40/39.5
	Spain	Enterobacteriales	30.3	NS	[84]
	Switzerland	Enterobacter spp.; Escherichia coli; Klebsiella pneumoniae	77; 8; 11	Mix	[50]

BSI: Bloodstream infections; VAP: Ventilator-associated pneumonia; HAC: Hospital-acquired condition; NS: Not specified; Mix: More than one infection site or aggregated data about them.